Category Archives: Intrinsa

A little bit more on the medicalisation of sex

TweetIt’s been a while since I’ve written about medicalisation. Which seems as good an excuse as any to revisit this issue and reflect on some of the developments in this area in healthcare, therapy and media. A few months ago I took part in the 41st Maudsley Debate entitled ‘Love is a Drug’. Ben Goldacre [...]
Also posted in Activism and Open Access, Bad science, Commercialisation, Erectile Dysfunction, Evidence based, Female Sexual Dysfunction, Flibanserin, Gender, Journalism, Medicalisation, Orgasm, Premature Ejaculation | Comments closed

Is low sexual desire in women a disease? No it’s not. But drug company are seeking FDA approval for a drug to ‘cure’ women nonetheless

TweetOn June 18th pharmaceutical company Boehringer Ingelheim will be seeking approval from the Food and Drug Administration (FDA) for their drug Flibanserin (which may be traded under the names of Ectris and/or Girosa). This is an antidepressant style drug which Boehringer Ingelheim claim is a treatment for low/lack of sexual desire in women (aka Hypoactive [...]
Also posted in Activism and Open Access, Female Sexual Dysfunction, Flibanserin, Medicalisation | Comments closed

New trials of female sexual dysfunction drug (Flibanserin) will be reported this week

Here's the back plot to this latest drug for female sexual dysfunction and questions you should be asking about Flibanserin.
Also posted in Activism and Open Access, Desire, Female Sexual Dysfunction, Flibanserin, Intercourse, Journalism, Medicalisation, Orgasm, PT141, RCTs, Research, Sexual dysfunction, Viagra | Comments closed